VIVEbiotech will participate in the ESGCT 2025 Annual Congress in Seville

VIVEbiotech will participate in the Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), which this year is being organised in collaboration with the Spanish Society of Gene and Cell Therapy (SETGyC).

The congress will be held from 7 to 10 October in the city of Seville, at the FIBES – Conference and Exhibition Centre, an ideal setting for bringing together professionals in the field of gene and cell therapy from all over Europe and beyond.

You can find us at stand D31, where we will be delighted to welcome our current partners, meet potential new collaborators, and share knowledge in an environment marked by scientific excellence and professional exchange.

The VIVEbiotech team attending the event consists of:

• Natalia Elizalde, Chief Business Development Officer

• Marie Fertin, Chief Custom Solution & Process Development Officer

• Miguel Álvarez, Technical Proposals Technician

• Miren Zuazo, Customer Project Transfer Manager

• Víctor Martínez Polo, Business Development Manager

During the conference, we hope to hold follow-up discussions with our clients, explore new opportunities for collaboration, learn from the scientific advances presented, and, of course, share good times with colleagues and friends in the sector.